Guido Buonincontri1, Nigel I Wood2, Simon G Puttick2, Alex O Ward1, T Adrian Carpenter1, Stephen J Sawiak3, A Jennifer Morton2. 1. Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK, CB2 0QQ. 2. Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Site, Cambridge, UK, CB2 3DY. 3. Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK, CB2 0QQ ; Behavioural and Clinical Neuroscience Institute, Department of Experimental Psychology, University of Cambridge, Downing Site, Cambridge, UK, CB2 3EB.
Abstract
BACKGROUND: Increasingly, evidence from studies in both animal models and patients suggests that cardiovascular dysfunction is important in HD. Previous studies measuring function of the left ventricle (LV) in the R6/2 model have found a clear cardiac abnormality, albeit with preserved LV systolic function. It was hypothesized that an impairment of RV function might play a role in this condition via mechanisms of ventricular interdependence. OBJECTIVE: To investigate RV function in the R6/2 mouse model of Huntington's disease (HD). METHODS: Cardiac cine-magnetic resonance imaging (MRI) was used to determine functional parameters in R6/2 mice. In a first experiment, these parameters were derived longitudinally to determine deterioration of cardiac function with disease progression. A second experiment compared the response to a stress test (using dobutamine) of wildtype and early-symptomatic R6/2 mice. RESULTS: There was progressive deterioration of RV systolic function with age in R6/2 mice. Furthermore, beta-adrenergic stimulation with dobutamine revealed RV dysfunction in R6/2 mice before any overt symptoms of the disease were apparent. CONCLUSIONS: This work adds to accumulating evidence of cardiovascular dysfunction in R6/2 mice, describing for the first time the involvement of the right ventricle. Cardiovascular dysfunction should be considered, both when treatment strategies are being designed, and when searching for biomarkers for HD.
BACKGROUND: Increasingly, evidence from studies in both animal models and patients suggests that cardiovascular dysfunction is important in HD. Previous studies measuring function of the left ventricle (LV) in the R6/2 model have found a clear cardiac abnormality, albeit with preserved LV systolic function. It was hypothesized that an impairment of RV function might play a role in this condition via mechanisms of ventricular interdependence. OBJECTIVE: To investigate RV function in the R6/2 mouse model of Huntington's disease (HD). METHODS: Cardiac cine-magnetic resonance imaging (MRI) was used to determine functional parameters in R6/2 mice. In a first experiment, these parameters were derived longitudinally to determine deterioration of cardiac function with disease progression. A second experiment compared the response to a stress test (using dobutamine) of wildtype and early-symptomatic R6/2 mice. RESULTS: There was progressive deterioration of RV systolic function with age in R6/2 mice. Furthermore, beta-adrenergic stimulation with dobutamine revealed RV dysfunction in R6/2 mice before any overt symptoms of the disease were apparent. CONCLUSIONS: This work adds to accumulating evidence of cardiovascular dysfunction in R6/2 mice, describing for the first time the involvement of the right ventricle. Cardiovascular dysfunction should be considered, both when treatment strategies are being designed, and when searching for biomarkers for HD.
Entities:
Keywords:
Huntington’s Disease; MRI; cognitive function; heart failure; right ventricle
Authors: K Sathasivam; C Hobbs; M Turmaine; L Mangiarini; A Mahal; F Bertaux; E E Wanker; P Doherty; S W Davies; G P Bates Journal: Hum Mol Genet Date: 1999-05 Impact factor: 6.150
Authors: A Jennifer Morton; Nigel I Wood; Michael H Hastings; Carrie Hurelbrink; Roger A Barker; Elizabeth S Maywood Journal: J Neurosci Date: 2005-01-05 Impact factor: 6.167
Authors: Michael J Mihm; Deborah M Amann; Brandon L Schanbacher; Ruth A Altschuld; John Anthony Bauer; Kari R Hoyt Journal: Neurobiol Dis Date: 2006-11-27 Impact factor: 5.996
Authors: Guido Buonincontri; Carmen Methner; Thomas Krieg; T Adrian Carpenter; Stephen J Sawiak Journal: J Magn Reson Imaging Date: 2013-01-04 Impact factor: 4.813
Authors: Tamara S Cutler; Saemi Park; Dawn H Loh; Maria C Jordan; Tomohiro Yokota; Kenneth P Roos; Cristina A Ghiani; Christopher S Colwell Journal: Physiol Rep Date: 2017-06
Authors: Analyne M Schroeder; Huei Bin Wang; Saemi Park; Maria C Jordan; Fuying Gao; Giovanni Coppola; Michael C Fishbein; Kenneth P Roos; Cristina A Ghiani; Christopher S Colwell Journal: PLoS One Date: 2016-01-25 Impact factor: 3.240
Authors: Kyle D Fink; Peter Deng; Audrey Torrest; Heather Stewart; Kari Pollock; William Gruenloh; Geralyn Annett; Teresa Tempkin; Vicki Wheelock; Jan A Nolta Journal: Regen Med Date: 2015 Impact factor: 3.806
Authors: Jessica J Steventon; Hannah Furby; James Ralph; Peter O'Callaghan; Anne E Rosser; Richard G Wise; Monica Busse; Kevin Murphy Journal: Brain Commun Date: 2020-04-16